Viserve Enterprise Public Company Limited

As of June 30, 2026, Viserve Enterprise Public Company Limited NVDR carries a market capitalization of 67.50M, placing it among publicly traded companies globally. Its enterprise value stands at 90.39M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Viserve Enterprise Public Company Limited NVDR has 250.00M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.48, and the price-to-book ratio stands at 1.56.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.72 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 90.39M versus a market cap of 67.50M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Viserve Enterprise Public Company Limited NVDR maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 65.00, indicating elevated leverage, while an interest coverage ratio of -1.85 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Viserve Enterprise Public Company Limited NVDR posted a negative return on equity (ROE) of -23.67, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -13.60, reflecting losses generated across the asset base. The company generates approximately 117,342.67 in revenue per employee across its workforce of 449.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Viserve Enterprise Public Company Limited NVDR's stock has declined approximately 32.35% over the past 52 weeks. The 50-day moving average sits at 0.26, while the 200-day moving average is 0.28.

Over the twelve months ended June 30, 2026, Viserve Enterprise Public Company Limited NVDR generated 52.69M in revenue and converted that into -11.64M in net income, yielding earnings per share of -0.04. EBITDA reached -2.07M, while operating income came in at -10.49M.

As of June 30, 2026, Viserve Enterprise Public Company Limited NVDR holds 5.25M in cash and equivalents against 28.14M in total debt, resulting in a net debt position of 5.53M. Total book value stands at 43.28M, with working capital of 706,838.00 providing operational flexibility.

Viserve Enterprise Public Company Limited NVDR produced 1.23M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -334,986.00 in capital expenditures, free cash flow totaled 892,454.00 - equivalent to 0.00 per share.

Over the twelve months ended June 30, 2026, Viserve Enterprise Public Company Limited NVDR posted a gross margin of 19.97, reflecting its pricing power and cost economics. The operating margin of -19.90 and net profit margin of -22.08 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Viserve Enterprise Public Company Limited NVDR paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 1.15, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.04, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Viserve Enterprise Public Company Limited NVDR shareholders.

Viserve Enterprise Public Company Limited NVDR's most recent stock split took place on November 27, 2024 with a 55:59 split ratio.

As of June 30, 2026, Viserve Enterprise Public Company Limited NVDR has an Altman Z-Score of -2.30, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.